Skip to Content
Merck
All Photos(2)

Key Documents

Safety Information

A7791

Sigma-Aldrich

N-Acetyl-D-lactosamine

≥98% (TLC)

Synonym(s):

β-D-Gal-(1→4)-D-GlcNAc, 2-Acetamido-2-deoxy-4-O-β-D-galactopyranosyl-D-glucopyranose, LN, N-Acetyl-4-O-(β-D-galactopyranosyl)-D-glucosamine

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C14H25NO11
CAS Number:
32181-59-2
Molecular Weight:
383.35
Beilstein:
96808
MDL number:
MFCD00063785
UNSPSC Code:
12352201
PubChem Substance ID:
24891280
NACRES:
NA.25
Pricing and availability is not currently available.

Assay

≥98% (TLC)

form

powder

optical activity

[α]25/D 27.5 to 33.5 °, c = 0.5% (w/v) in water

technique(s)

thin layer chromatography (TLC): suitable

impurities

≤8% water

color

white

mp

170 -185  °C ((338 - 365 °F ))

solubility

water: 50 mg/mL, clear to very slightly hazy, colorless to faintly yellow

storage temp.

−20°C

SMILES string

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

InChI

1S/C14H25NO11/c1-4(18)15-7-9(20)12(6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8+,9-,10+,11-,12-,13?,14+/m1/s1

InChI key

KFEUJDWYNGMDBV-RPHKZZMBSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

N-Acetyl-D-lactosamine is used as a specific lectin target molecule in the identification and differentiation of sugar binding molecules such as the galectins. N-Acetyl-D-lactosamine is used in studies of galactosidase, fucosyltransferase, sialyltransferase, and lectin inhibition.
Useful in studies of galactosidase, fucosyltransferase, sialyltransferase, and lectin inhibition.

Preparation Note

Synthetic

Other Notes

To gain a comprehensive understanding of our extensive range of Disaccharides for your research, we encourage you to visit our Carbohydrates Category page.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

A7791-BULK:
A7791-100MG:
A7791-5MG:
A7791-25MG:
A7791-10MG:
A7791-VAR:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCK1081
BCCJ2846
BCCG0659
BCCD3085
BCCB5285

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Moritz Augustin et al.
PLoS computational biology, 13(6), e1005545-e1005545 (2017-06-24)
The spiking activity of single neurons can be well described by a nonlinear integrate-and-fire model that includes somatic adaptation. When exposed to fluctuating inputs sparsely coupled populations of these model neurons exhibit stochastic collective dynamics that can be effectively characterized
Paulina Sindrewicz et al.
Scientific reports, 9(1), 11851-11851 (2019-08-16)
Galectins are involved in the regulation of divergent physiological and pathological processes and are increasingly recognized to play important roles in a number of diseases. However, a simple and effective way in assessing galectin-ligand interactions is lacking. Our examination of
Vanessa Dumeaux et al.
PLoS computational biology, 13(9), e1005680-e1005680 (2017-09-29)
Although systemic immunity is critical to the process of tumor rejection, cancer research has largely focused on immune cells in the tumor microenvironment. To understand molecular changes in the patient systemic response (SR) to the presence of BC, we profiled
Joseph Darbellay et al.
EBioMedicine, 25, 73-86 (2017-11-04)
Outcomes of Zika virus (ZIKV) infection in pregnant women vary from the birth of asymptomatic offspring to abnormal development and severe brain lesions in fetuses and infants. There are concerns that offspring affected in utero and born without apparent symptoms
Frank Liang et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 25(12), 2635-2647 (2017-09-30)
mRNA vaccines are rapidly emerging as a powerful platform for infectious diseases because they are well tolerated, immunogenic, and scalable and are built on precise but adaptable antigen design. We show that two immunizations of modified non-replicating mRNA encoding influenza
View All Related Papers

Articles

Review of O-Linked Glycoproteins

O-Linked glycoproteins are usually large proteins with a molecular mass of >200 kDa. Glycosylation generally occurs in high-density clusters and may represent as much as 50-80% of the overall mass.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service